Skip to main content

Table 1 Biochemical and hormonal investigations

From: Misleading localization by 18F-fluorocholine PET/CT in familial hypocalciuric hypercalcemia type-3: a case report

 

Dec

2013

Aug 2014

Sept 2015

Sept

2016

May 2017

April 2018

Dec 2018

Mar

2019

July 2019

Sept

2019

Mar 2020

Pre

Post

Serum calcium, mmol/L (NL, 2.1–2.6)

2.67

2.68

2.71

2.67

2.76

2.69

2.89

2.87

2.51

2.57

2.70

2.75

PTH, ng/l (NR, 15–65)

71.6

73

94.8

70.8

85.5

58.7

70.4

63.7

 

58.9

67.6

 

25-hydroxy vitamin D, nmol/L (NL, > 75)

  

13

46

26

49

28.2

41.7

  

45

 

Serum phosphate, mmol/L (NL, 0.9–1.5)

0.94

0.79

1.14

0.91

0.87

0.67

0.83

0.69

0.93

1.02

0.81

0.84

Serum magnesium, mmol/L (NL, 0.7-1)

0.89

0.88

0.87

0.84

0.91

0.85

0.89

0.87

0.86

0.84

0.84

0.87

Serum creatinine, umol/L (NL, 46–69)

  

58

 

56

 

54

46

52

 

52

57

24-h urine calcium, mmol/day (NL, 2.5–7.5)

1.92

2.74

 

2.32

 

2.83

3.93

6.99

 

3.19

3.35

Urine volume (L)

1.56

1.27

 

1.7

 

1.83

2.37

1.78

 

0.77

1.66

24-h urine creatinine, mmol/day (NL, 6–15)

       

13.6

  

10.2

CCCR

       

0.008

  

0.007

Spot urine calcium, mmol/L

1.23

2.16

 

3.14

3.99

1.55

1.66

3.93

 

4.15

2.02

Spot urine creatinine, mmol/L

       

11

  

6

Spot urine calcium/creatinine ratio (NL, Ë‚0.39)a

       

0.36

  

0.34

  1. NL normal range, PTH parathyroid hormone, CCCR calcium creatinine clearance ratio. Pre and Post refer to date immediately before and after parathyroidectomy. aCalculated as calcium (mmol/L)/creatinine (mmol/L), hypercalciuric range is > 0.56